SPRUCE BIOSCIENCES, INC. - SPRB

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$48.3M

QoQ value delta ($000)

-$17.29M (-26.36%)

Implied price effect (QoQ)

-24.3%

Total shares

733,335

QoQ shares delta

-20,520 (-2.72%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 29 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Ikarian Capital, LLC	7,930	121,356	0.64%
MILLENNIUM MANAGEMENT LLC	7,311	111,888	0.0%
CITADEL ADVISORS LLC	4,574	69,999	0.0%
ADAR1 Capital Management, LLC	3,829	58,600	0.23%
Alyeska Investment Group, L.P.	3,376	51,671	0.01%
WELLINGTON MANAGEMENT GROUP LLP	3,188	48,796	0.0%
BOOTHBAY FUND MANAGEMENT, LLC	2,749	42,080	0.04%
BALYASNY ASSET MANAGEMENT L.P.	2,614	40,000	0.0%
Carlyle Group Inc.	2,523	38,620	0.02%
Quinn Opportunity Partners LLC	1,752	26,810	0.09%
VANGUARD GROUP INC	1,556	17,873	0.0%
ExodusPoint Capital Management, LP	1,437	22,000	0.01%
BlackRock, Inc.	1,106	16,938	0.0%
GEODE CAPITAL MANAGEMENT, LLC	842	12,889	0.0%
Squadron Capital Management LLC	797	12,200	0.29%
DIADEMA PARTNERS LP	653	10,000	0.11%
STEMPOINT CAPITAL LP	415	6,360	0.08%
GOLDMAN SACHS GROUP INC	359	5,506	0.0%
STATE STREET CORP	352	5,400	0.0%
Resolute Capital Asset Partners LLC	261	4,000	0.14%
UBS Group AG	256	3,919	0.0%
Persistent Asset Partners Ltd	165	2,528	0.06%
MORGAN STANLEY	92	1,415	0.0%
Lion Point Capital, LP	65	1,000	0.39%
CITIGROUP INC	61	939	0.0%